The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Powell, W. S.
Right arrow Articles by Gravel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powell, W. S.
Right arrow Articles by Gravel, S.

The Journal of Immunology, Vol 154, Issue 8 4123-4132, Copyright © 1995 by American Association of Immunologists


ARTICLES

5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration

WS Powell, D Chung and S Gravel
Meakins-Christie Laboratories, Department of Medicine, McGill University, Montreal, Quebec, Canada.

Human neutrophils and monocytes contain a highly specific dehydrogenase which converts 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE) to 5- oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE). We have previously shown that 5-oxo-ETE is a potent stimulus of neutrophil calcium levels and migration and have now investigated its effects on human eosinophils. 5-Oxo-ETE is a potent stimulus of eosinophil migration, with significant effects being detected at concentrations as low as 1 nM and a maximal response at 1 microM. The responses elicited by 5-oxo- ETE were about two to three times greater than those to platelet- activating factor (PAF) and 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid (5-oxo-15-hydroxy-ETE) at all concentrations tested between 10 nM and 1 microM. Leukotrienes B4 and D4 also significantly stimulated eosinophil migration, but the maximal responses to these agonists were only about 4% of the maximal response to 5-oxo-ETE. A low concentration of 5-oxo-ETE (1 nM) potentiated eosinophil migration in response to PAF. Eosinophils were capable of converting 5-HETE to 5-oxo-ETE, and this reaction was enhanced by phorbol myristate acetate. Stimulation of eosinophils with A23187 in the presence of low concentrations of arachidonic acid and phorbol 12-myristate 13-acetate led to the formation of 5-oxo-ETE and 5-oxo-15-hydroxy-ETE, but the amounts were considerably less than those of other eicosanoids such as leukotriene C4, cysteine-containing lipoxins, and 5,15-dihydroxy-6E,8Z,11Z,13E- eicosatetraenoic acid. In summary, of all the lipid mediators tested, 5- oxo-ETE was the most effective in stimulating migration of human eosinophils. Although eosinophils are capable of synthesizing 5-oxo- eicosanoids, the amounts detected were relatively small, and other leukocytes such as neutrophils, monocytes, or macrophages may be more important sites for the synthesis of this compound.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. Patel, C. Cossette, J. R. Anumolu, S. Gravel, A. Lesimple, O. A. Mamer, J. Rokach, and W. S. Powell
Structural Requirements for Activation of the 5-Oxo-6E,8Z, 11Z,14Z-eicosatetraenoic Acid (5-Oxo-ETE) Receptor: Identification of a Mead Acid Metabolite with Potent Agonist Activity
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 698 - 707.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. A. Cormier, A. G. Taranova, C. Bedient, T. Nguyen, C. Protheroe, R. Pero, D. Dimina, S. I. Ochkur, K. O'Neill, D. Colbert, et al.
Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response
J. Leukoc. Biol., June 1, 2006; 79(6): 1131 - 1139.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
D. Koike, H. Obinata, A. Yamamoto, S. Takeda, H. Komori, F. Nara, T. Izumi, and T. Haga
5-Oxo-Eicosatetraenoic Acid-Induced Chemotaxis: Identification of a Responsible Receptor hGPCR48 and Negative Regulation by G Protein G12/13.
J. Biochem., March 1, 2006; 139(3): 543 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell
Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 64 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Monneret, R. Boumiza, S. Gravel, C. Cossette, J. Bienvenu, J. Rokach, and W. S. Powell
Effects of Prostaglandin D2 and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by Basophils
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 627 - 634.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Oka, S. Ikeda, S. Kishimoto, M. Gokoh, S. Yanagimoto, K. Waku, and T. Sugiura
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils
J. Leukoc. Biol., November 1, 2004; 76(5): 1002 - 1009.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. Mercier, C. Morin, M. Cloutier, S. Proteau, J. Rokach, W. S. Powell, and E. Rousseau
5-Oxo-ETE regulates tone of guinea pig airway smooth muscle via activation of Ca2+ pools and Rho-kinase pathway
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L631 - L640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-R. Erlemann, J. Rokach, and W. S. Powell
Oxidative Stress Stimulates the Synthesis of the Eosinophil Chemoattractant 5-Oxo-6,8,11,14-eicosatetraenoic Acid by Inflammatory Cells
J. Biol. Chem., September 24, 2004; 279(39): 40376 - 40384.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. B. Stamatiou, C.-C. Chan, G. Monneret, D. Ethier, J. Rokach, and W. S. Powell
5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates the Release of the Eosinophil Survival Factor Granulocyte/Macrophage Colony-stimulating Factor from Monocytes
J. Biol. Chem., July 2, 2004; 279(27): 28159 - 28164.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Mrsny, A. T. Gewirtz, D. Siccardi, T. Savidge, B. P. Hurley, J. L. Madara, and B. A. McCormick
From The Cover: Identification of hepoxilin A3 in inflammatory events: A required role in neutrophil migration across intestinal epithelia
PNAS, May 11, 2004; 101(19): 7421 - 7426.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. Brink, S.-E. Dahlen, J. Drazen, J. F. Evans, D. W. P. Hay, G. E. Rovati, C. N. Serhan, T. Shimizu, and T. Yokomizo
International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
Pharmacol. Rev., March 1, 2004; 56(1): 149 - 157.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M-J. Dallaire, C. Ferland, N. Page, S. Lavigne, F. Davoine, and M. Laviolette
Endothelial cells modulate eosinophil surface markers and mediator release
Eur. Respir. J., June 1, 2003; 21(6): 918 - 924.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Zarini and R. C. Murphy
Biosynthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid from 5-Hydroperoxyeicosatetraenoic Acid in the Murine Macrophage
J. Biol. Chem., March 21, 2003; 278(13): 11190 - 11196.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. E. Jones, S. Holden, L. Tenaillon, U. Bhatia, K. Seuwen, P. Tranter, J. Turner, R. Kettle, R. Bouhelal, S. Charlton, et al.
Expression and Characterization of a 5-oxo-6E,8Z,11Z,14Z-Eicosatetraenoic Acid Receptor Highly Expressed on Human Eosinophils and Neutrophils
Mol. Pharmacol., March 1, 2003; 63(3): 471 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Monneret, C. Cossette, S. Gravel, J. Rokach, and W. S. Powell
15R-Methyl-Prostaglandin D2 Is a Potent and Selective CRTH2/DP2 Receptor Agonist in Human Eosinophils
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Monneret, H. Li, J. Vasilescu, J. Rokach, and W. S. Powell
15-Deoxy-{Delta}12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils
J. Immunol., April 1, 2002; 168(7): 3563 - 3569.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Monneret, S. Gravel, M. Diamond, J. Rokach, and W. S. Powell
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
Blood, September 15, 2001; 98(6): 1942 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. E. Boden, S. Schweizer, T. Bertsche, M. Dufer, G. Drews, and H. Safayhi
Stimulation of Leukotriene Synthesis in Intact Polymorphonuclear Cells by the 5-Lipoxygenase Inhibitor 3-oxo-Tirucallic Acid
Mol. Pharmacol., August 1, 2001; 60(2): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Ferland, M. Guilbert, F. Davoine, N. Flamand, J. Chakir, and M. Laviolette
Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system
J. Leukoc. Biol., May 1, 2001; 69(5): 772 - 778.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. M. Hevko, R. C. Bowers, and R. C. Murphy
Synthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid and Identification of Novel omega -Oxidized Metabolites in the Mouse Macrophage
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 293 - 305.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
T. Urasaki, J. Takasaki, T. Nagasawa, and H. Ninomiya
Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway
J. Leukoc. Biol., January 1, 2001; 69(1): 105 - 112.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. Rose, L. Kiss, F. Grimminger, K. Mayer, U. Grandel, W. Seeger, E. Bieniek, and U. Sibelius
E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid
Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L100 - L109.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. T. O'Flaherty, J. S. Taylor, and M. Kuroki
The Coupling of 5-Oxo-Eicosanoid Receptors to Heterotrimeric G Proteins
J. Immunol., March 15, 2000; 164(6): 3345 - 3352.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. J. MacLeod, P. Lembessis, J. R. Hamilton, and W. S. Powell
5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates Isotonic Volume Reduction of Guinea Pig Jejunal Crypt Epithelial Cells
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 511 - 516.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Guilbert, C. Ferland, M. Bossé, N. Flamand, S. Lavigne, and M. Laviolette
5-Oxo-6,8,11,14-Eicosatetraenoic Acid Induces Important Eosinophil Transmigration through Basement Membrane Components . Comparison of Normal and Asthmatic Eosinophils
Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 97 - 104.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Janabi, I. Hau, and M. Tardieu
Negative Feedback Between Prostaglandin and {alpha}- and {beta}-Chemokine Synthesis in Human Microglial Cells and Astrocytes
J. Immunol., February 1, 1999; 162(3): 1701 - 1706.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. S. Powell, S. Gravel, S. P. Khanapure, and J. Rokach
Biological Inactivation of 5-oxo-6,8,11,14-Eicosatetraenoic Acid by Human Platelets
Blood, February 1, 1999; 93(3): 1086 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
W. S. Powell, S. Gravel, and F. Halwani
5-oxo-6,8,11,14-Eicosatetraenoic Acid Is a Potent Stimulator of L-Selectin Shedding, Surface Expression of CD11b, Actin Polymerization, and Calcium Mobilization in Human Eosinophils
Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 163 - 170.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. T. O'Flaherty, J. S. Taylor, and M. J. Thomas
Receptors for the 5-Oxo Class of Eicosanoids in Neutrophils
J. Biol. Chem., December 4, 1998; 273(49): 32535 - 32541.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Berhane, A. A. Ray, S. P. Khanapure, J. Rokach, and W. S. Powell
Calcium/Calmodulin-dependent Conversion of 5-Oxoeicosanoids to 6,7-Dihydro Metabolites by a Cytosolic Olefin Reductase in Human Neutrophils
J. Biol. Chem., August 14, 1998; 273(33): 20951 - 20959.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Dunzendorfer, P. Schratzberger, N. Reinisch, C. M. Kahler, and C. J. Wiedermann
Secretoneurin, a Novel Neuropeptide, Is a Potent Chemoattractant for Human Eosinophils
Blood, March 1, 1998; 91(5): 1527 - 1532.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. T. O'Flaherty, M. Kuroki, A. B. Nixon, J. Wijkander, E. Yee, S. L. Lee, P. K. Smitherman, R. L. Wykle, and L. W. Daniel
5-Oxo-eicosanoids and Hematopoietic Cytokines Cooperate in Stimulating Neutrophil Function and the Mitogen-activated Protein Kinase Pathway
J. Biol. Chem., July 26, 1996; 271(30): 17821 - 17828.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.